Satisfaction with tablet treatment and meal/snack timing amongst people with sulphonylurea-treated Type 2 diabetes. March 11, 2004 Read More »
Improved Treatment Satisfaction and Quality of Life with Insulin Glargine + Lispro compared with NPH Insulin + Regular Human Insulin in Patients with Type 1 Diabetes January 1, 2004 Read More »
Design of an individualised measure of the impact of diabetes on the quality of life of elderly people: the ADDQoL Senior. November 1, 2003 Read More »
Psychometric evaluation of an individualised measure of men’s perceived impact of age-related decline in hormone levels on their quality of life (QoL): the A-RHDQoL. November 1, 2003 Read More »
Psychometric properties of a new individualised measure of quality of life (QoL) for teenagers with diabetes mellitus: the ADDQoL-Teen. November 1, 2003 Read More »
Preliminary development of a new individualised questionnaire measuring quality of life in older men with age-related hormonal decline: the A-RHDQoL. October 6, 2003 Read More »
Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. October 1, 2003 Read More »
Improved treatment satisfaction and perceived metabolic control with insulin glargine, regardless of whether injected before breakfast, dinner or bedtime, in patients with Type 1 diabetes. June 1, 2003 Read More »
Evaluation of two health status measures in adults with growth hormone deficiency. April 1, 2003 Read More »
Patient experiences of treatment for diabetic retinopathy: development of a retinopathy-specific treatment satisfaction questionnaire. March 11, 2003 Read More »
Improved treatment satisfaction and perceived metabolic control with insulin glargine, regardless of whether injected before breakfast, dinner or bedtime, in patients with Type 1 diabetes. January 1, 2003 Read More »
Design of the MacDQoL individualised measure of the impact of macular disease on quality of life. November 1, 2002 Read More »
DAFNE: authors’ response to electronic letters from 5th October to 22nd October 2002. October 29, 2002 Read More »
DAFNE: improved quality of life as a result of intensified treatment is counter-intuitive to many clinicians. October 5, 2002 Read More »
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: the dose adjustment for normal eating (DAFNE) randomised controlled trial. October 5, 2002 Read More »
Patient perceptions of diabetes and diabetes therapy: assessing quality of life. September 1, 2002 Read More »
Assessing the quality of life of adolescents with diabetes: using the SEIQoL, DQOL, patient and diabetes specialist nurse ratings. July 31, 2002 Read More »
Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society July 1, 2002 Read More »
How does diabetic retinopathy affect quality of life? Interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL April 21, 2002 Read More »
The Dose Adjustment For Normal Eating (DAFNE) project. The end of the diabetic diet in Type 1 diabetes. April 21, 2002 Read More »
The W-BQ28 measure of generic and diabetes-specific well-being is shown to be reliable, valid and sensitive to change in DIABQoL+ and DAFNE studies. April 21, 2002 Read More »
Risk assessment for developing Type 1 diabetes: Intentions of behavioural changes prior to risk notification. January 1, 2002 Read More »
Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes. August 1, 2001 Read More »
Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease. August 1, 2001 Read More »
FIT: A paradigm shift that recognises the importance of dietary freedom and quality of life in diabetes management. July 1, 2001 Read More »
DAFNE (Dose Adjustment For Normal Eating): Methodology and Quality Assurance for Exploratory trial. April 1, 2001 Read More »
The Dose Adjustment For Normal Eating (DAFNE) Trial: What makes people with Type 1 diabetes agree/decline to participate? April 1, 2001 Read More »
Psychological effects of withdrawal of growth hormone (GH) therapy from GH-deficient adults. March 1, 2001 Read More »
Three months’ withdrawal of growth hormone (GH) therapy from GH-deficient adults does not affect cognitive functioning. March 1, 2001 Read More »
More good than harm: a randomised controlled trial of education about familial risk of diabetes on psychological outcomes. November 1, 2000 Read More »
Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: assessment of improvements in treatment satisfaction with a new insulin analogue. September 1, 2000 Read More »
Improved psychological outcomes after initiation of insulin treatment in patients with type II diabetes. August 1, 2000 Read More »
ADDQoL indicates negative impact of diabetes on quality of life despite high levels of satisfaction with treatment. August 1, 2000 Read More »
Psychometric evaluation of Diabetes Treatment Satisfaction Questionnaire in 8 languages. August 1, 2000 Read More »
Diabetes Treatment Satisfaction Questionnaire (change) in English and German evaluated in insulin glargine trials. August 1, 2000 Read More »
The 12-item Well-Being Questionnaire. Origins, current stage of development, and availability. June 1, 2000 Read More »
Quality of Life with Peritoneal Dialysis (PD). An evaluation using the Renal Dependent Quality of Life Questionnaire (RDQoL). April 1, 2000 Read More »
Validation of the Genital Herpes Treatment Satisfaction Questionnaire (GHERPTSQ) in status and change versions. March 1, 2000 Read More »
A comparison of the psychometric properties of quality of life and related measures (GWBI, W-BQ12, NHP, SF-36 and HDQoL) for use in research into adult growth hormone deficiency (GHD). March 1, 2000 Read More »
A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. March 1, 2000 Read More »
The W-BQ 28: further development of the Well-being Questionnaire to include diabetes-specific as well as generic subscales and new stress subscales. February 1, 2000 Read More »
